Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
NextGen Jane, Inc. currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. Each of these actions is assigned to a different individual, as evidenced by the 3 distinct examiners currently engaged with the portfolio. This distribution is mirrored in the organizational structure of the patent office, with the matters being handled across 3 distinct art units.
The busiest examiner for this company is MCCORMACK, ERIN KATHLEEN, who is responsible for 1 pending office action. With 3 pending office actions spread across an equal number of examiners and art units, the prosecution strategy appears to involve a variety of specific technical niches within the broader biotechnology field. No single examiner dominates the current interactions.
The fact that 3 distinct examiners are reviewing the pending matters suggests a lack of examiner concentration. Because each action is in a different one of the 3 distinct art units, the company must manage separate technical dialogues simultaneously. This profile indicates that the pending office actions represent distinct innovations that do not overlap enough to be grouped under a single examiner within the Biotechnology & Pharmaceuticals sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCORMACK, ERIN KATHLEEN | 1 | 8.6% | +50.0% |
| SCHUBERG, LAURA J | 1 | 23.6% | +37.0% |
| GRAY, JESSICA | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258714 | SYSTEMS AND METHODS FOR PRESERVATION OF A CERVICOVAGINAL FLUID SAMPLE | MCCORMACK, ERIN KATHLEEN | 10d overdue |
| 18014568 | FETAL TROPHOBLAST COMPOSITIONS AND METHODS | SCHUBERG, LAURA J | — |
| 17772829 | METHODS AND SYSTEMS FOR MENSTRUALOME ANALYSIS | GRAY, JESSICA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258714 | SYSTEMS AND METHODS FOR PRESERVATION OF A CERVICOVAGINAL FLUID SAMPLE | MCCORMACK, ERIN KATHLEEN | 10d overdue |
| 18014568 | FETAL TROPHOBLAST COMPOSITIONS AND METHODS | SCHUBERG, LAURA J | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| 1631 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18258714 | SYSTEMS AND METHODS FOR PRESERVATION OF A CERVICOVAGINAL FLUID SAMPLE | MCCORMACK, ERIN KATHLEEN | 3791 | §103§112 | Non-Final OA | 10d overdue | Pending | Jun 21, 2023 |
| 18014568 | FETAL TROPHOBLAST COMPOSITIONS AND METHODS | SCHUBERG, LAURA J | 1631 | §102§103 | Final Rejection | — | Pending | Jan 05, 2023 |
| 17772829 | METHODS AND SYSTEMS FOR MENSTRUALOME ANALYSIS | GRAY, JESSICA | 1682 | §101§112DP | Final Rejection | — | Pending | Apr 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial